(Lyso-PPC), 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine
(Lyso-SPC), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC),
1,2-disteraroyl-sn-glycero-3-phosphocholine (DSPC),
1-myristoyl-2-palmitoyl-sn-glycero-3-phosphocholine (MPPC),
1-myristoyl-2-stearoyl-sn-glycero-3-phosphocholine (MSPC),
and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-methoxy
polyetheneglycol-2000 (DSPE-PEG2k) were purchased from Avanti Polar Lipids Inc.
(Alabaster, AL). Triethanolamine (TEOA) and copper (II) gluconate were purchased
from Sigma (St. Louis, MO). Gemcitabine hydrochloride was purchased from LC
Laboratories (Woburn, MA).
KPC (mT4) cells were a gift from Dr. David Tuveson (Cold Spring Harbor
Laboratory, Cold Spring Harbor, NY). KPC cells were cultured in
Dulbecco’s Modified Eagle medium (DMEM) containing 4500 mg/L glucose,
L-glutamine and sodium pyruvate (# 11995, Invitrogen, San Diego, CA) and
supplemented with 10% fetal bovine serum and 1% penicillin–streptomycin.
The neu deletion (NDL) metastatic mammary carcinoma cell line
was a gift from Dr. Alexander Borowsky (University of California- Davis, Davis,
CA). NDL cells were cultured in high-glucose DMEM, supplemented with 10% fetal
bovine serum, 1% penicillin-streptomycin, 0.584 g/L L-glutamine and 0.110 g/L
sodium pyruvate. All cells were maintained at 37°C in a humidified 5%
CO2 incubator.